Status:

COMPLETED

PREPP: Preventing Postpartum Depression

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Postpartum Depression (PPD)

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

The primary aim of this study is to determine if a behavioral intervention targeting maternal caregiving of young infants can increase infant sleep and reduce fuss/cry behavior, and thereby (1) reduce...

Detailed Description

Of the nearly 4 million mothers delivering live births each year in the United States, approximately 560,000 - or 14% - will develop major or minor depression within the first four months postpartum, ...

Eligibility Criteria

Inclusion

  • Healthy pregnant women between 18-45 years old (based on self report)
  • A score of ≥19 on the Predictive Index of Postnatal Depression (PIPD), indicating risk for developing postpartum depression or score of ≥7 on the Edinburgh Postnatal Depression Scale
  • A healthy, singleton pregnancy (based on self report)
  • English speaking (based on self report)
  • Receiving standard prenatal care (based on self report)

Exclusion

  • Multi-fetal pregnancy (based on self-report)
  • Smoking, illicit drug use, or alcohol use during pregnancy (based on self-report)
  • Acute medical illness or significant pregnancy complication (based on self-report)
  • Currently in weekly, individual psychotherapy, including psychopharmacology (based on self report)
  • Psychotic d/o; Bipolar I; Major Depressive d/o (based on M.I.N.I.)

Key Trial Info

Start Date :

February 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2024

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT03283254

Start Date

February 12 2018

End Date

February 28 2024

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

New York State Psychiatric Institute

New York, New York, United States, 10032